We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Second Circuit to Hear Actavis’ Appeal on Namenda Decision
Second Circuit to Hear Actavis’ Appeal on Namenda Decision
The U.S. Court of Appeals for the Second Circuit Monday agreed to hear as soon as possible Actavis’ appeal of a lower court decision requiring it to keep an older formulation of its Alzheimer’s drug Namenda on shelves.